Could a simple inhaler prevent deadly pneumonia in ventilator patients?

NCT ID NCT07409727

Recruiting now Prevention Sponsor: Sarah Rabie Mohamed Adly Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether inhaling a medicine called N-acetylcysteine (NAC) can prevent pneumonia in critically ill patients who need a breathing machine. About 80 adults on ventilators will receive either NAC or a placebo. Researchers will track how many develop pneumonia and how long it takes, along with other breathing and infection measures.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENTILATION ACQUIRED PNEUMONIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

nosocomial infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VENTILATION ACQUIRED PNEUMONIA

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Cairo University Hospitals
RECRUITING

Cairo, 11011, Egypt

Contact Phone: •••-•••-•••• Email: •••••@•••••
Cairo University Hospitals
NOT_YET_RECRUITING

Cairo, Egypt

Contact Phone: •••-•••-•••• Email: •••••@•••••